SubHero Banner

Symjepi (epinephrine) – New formulation approval

September 27, 2018 - The FDA approved Adamis’ Symjepi (epinephrine) 0.15 mg injection for the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (eg, order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (eg, triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (eg, radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.

Download PDF